Farrell Granath
Analyst, Bank of America
Replay available
Alexandria Real Estate Equities, Inc. (NYSE: ARE) Q1 2026 earnings conference call, held 2026-04-28. Replay captured from the company's public earnings webcast.

Analyst, Bank of America
Analyst, Citi
Analyst, BMO Capital Markets
Analyst, Wells Fargo
Analyst, Green Street
Investor Relations
Executive Chairman and Founder
Chief Financial Officer
Analyst, Cantor Fitzgerald
Analyst, J.P. Morgan
Analyst, RBC Capital Markets
Analyst, Morgan Stanley
Analyst, Baird
Good day, and welcome to the Alexandria Real Estate Equities First Quarter 2026 Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad, and to withdraw your question, please press star then two. Please note, today's event is being recorded. I'd now like to turn the conference over to Paula Schwartz with Investor Relations. Please go ahead. Thank you, and good afternoon, everyone. This conference call contains forward-looking statements within the meaning of the federal securities laws. The company's actual results might differ materially from those projected in the forward-looking statements. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained in the company's periodic reports filed with the Securities and Exchange Commission. And now I'd like to turn the call over to Joel Marcus, Executive Chairman and Founder. Please go ahead, Joel. Thank you, Paula, and welcome everybody to our first quarter earnings call. With me today are Mark, Peter, and Jenna. First of all, as I always do, I want to say a thank you to our remarkable family team for their awesome efforts during a tough first quarter operating environment. And as they know well, we are motivated each and every day by our solemn mission to enable this precious life science industry, one of the most treasured and innovative industries on the face of the planet, to discover and bring to patients lifesaving and life-changing therapies. And how many of us, fr...